Related Experiment Video
Updated: Mar 13, 2026

07:22
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
4.7K
SPR-based assays enable the full functional analysis of bispecific molecules
W Meschendoerfer1, C Gassner1, F Lipsmeier2
1Large Molecule Research, Pharma Research and Early Development, Roche Innovation Center Munich, Germany.
Journal of Pharmaceutical and Biomedical Analysis
|October 11, 2016
Summary
Developing novel biotherapeutics like bispecific antibodies requires advanced functional characterization. New surface plasmon resonance (SPR) assays allow simultaneous or individual assessment of binding for efficient drug development.
Area of Science:
- Biochemistry
- Biotechnology
- Immunology
Background:
- Novel biotherapeutics, including bispecific antibodies and fusion proteins, present complex functional characterization challenges.
- Assessing bispecific antibodies requires evaluating two independent binding events and their interdependence, unlike standard antibodies.
Purpose of the Study:
- To develop and validate novel Surface Plasmon Resonance (SPR)-based assay principles for the comprehensive functional characterization of bispecific antibodies.
- To address limitations of existing bridging assays, such as potential changes in antigen activity upon immobilization.
Main Methods:
- Development of two SPR-based assay principles: one for simultaneous binding assessment and another for individual target assessment in solution.
- Comparison of data obtained from both assay principles to evaluate their correlation and reliability.
Main Results:
- Both SPR assay principles enable a "full" functional analysis of bispecific CrossMabs within a single assay setup.
- Simultaneous binding can be accurately calculated from individual target readouts, demonstrating a good correlation between the two methods.
Conclusions:
- The validated SPR assay principles provide efficient and reliable methods for the functional characterization of complex biotherapeutics.
- These assays facilitate efficient drug development by enabling comprehensive analysis of bispecific antibody binding characteristics.

